Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
12/2003
12/10/2003CN1130214C Medicine for treating purpura caused by lupus erythematosus and other immunological disease
12/10/2003CN1130213C Chinese herbal plaster for anti-canser and analgesic
12/10/2003CN1130209C Chinese medicine composition for curing sterility
12/10/2003CN1130208C Preparation for curing sexual impotence caused by inflammation of genital system
12/10/2003CN1130206C Mampalon penis product
12/09/2003US6660906 Tpl2 transgenic knockout mice
12/09/2003US6660723 Activating primate gamma delta lymphocytes
12/09/2003US6660523 Propagating preferential nervous system tissues; obtain tissue, incubate with preferential antigens, culture tissue, recover tissue
12/09/2003US6660521 Use of trans-activation and CIS-activation to increase the persistence of a transgene in an at least E4-deficient adenovirus
12/09/2003US6660520 Nrde
12/09/2003US6660305 Useful for the treatment of vitiligo; topically applying ethanol, an extract of human placenta, and calcium chloride
12/09/2003US6660264 Treatment of intracellular infection
12/09/2003US6660262 Trace minerals solution containing organic mineral elements; an Acidophilus sp. innoculum; vitamin A, vitamin D, and folic acid; cobalt amino acid chelates; and dried kelp,
12/09/2003US6660260 Bioprosthetic heart valves
12/09/2003US6660259 Herpes simplex virus for treating unwanted hyperproliferative cell growth
12/09/2003US6660257 Flt-3 receptor agonist proteins; nucleic acid sequence
12/09/2003US6659995 Autologous myocyte micro granual retrieval and implantation (AMMGRI)
12/09/2003US6659107 Sensitization of cells with porphyrins, then exposing to radiation and grafting; photodynamic therapy
12/09/2003CA2171462C Compounds for the prevention and treatment of helminth infections
12/09/2003CA1341449C Poly-kringle plasminogen activator
12/04/2003WO2003100087A2 Regulation of novel human asparagine-hydroxylases
12/04/2003WO2003100060A2 Muc-1 antigen with reduced number of vntr repeat units
12/04/2003WO2003100051A1 Palliative treatment for gluten intolerance
12/04/2003WO2003100045A1 Plant thymidine kinases and their use
12/04/2003WO2003100040A1 A method for generating antigen-presenting cells
12/04/2003WO2003100039A1 Method for the production of a three-dimensional flat tissue transplant
12/04/2003WO2003100038A1 Methods and compositions for expanding and differentiating insulin-producing cells
12/04/2003WO2003100026A2 Methods, compositions, and growth and differentiation factors for insulin-producing cells
12/04/2003WO2003100024A2 Treatment for diabetes
12/04/2003WO2003100023A2 Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration
12/04/2003WO2003100018A2 A bank of stem cells for transplantation
12/04/2003WO2003100011A2 Generation of histocompatible tissues using nuclear transplantation
12/04/2003WO2003100006A2 Method of improved prostate cancer detection
12/04/2003WO2003100005A2 Universal chimera bank
12/04/2003WO2003099859A2 Novel use of adenoviruses and nucleic acids coding therefor
12/04/2003WO2003099330A1 Induction and maintenance of tolerance to composite tissue allografts
12/04/2003WO2003099329A1 Chimeric allograft tolerance induction, monitoring and maintenance
12/04/2003WO2003099326A1 Novel uses of parapoxvirus preparations
12/04/2003WO2003099321A1 Methods for preventing, treating or delaying cardiac toxicity using neuregulin
12/04/2003WO2003099320A1 Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
12/04/2003WO2003099318A2 Pancreas-specific proteins
12/04/2003WO2003099312A1 Method for determining immune system affecting compounds
12/04/2003WO2003099301A1 Formulation containing tetrodotoxin for abstinence and analgecize which is administered through respiratory tract
12/04/2003WO2003099300A1 Neuregulin based methods and compositions for treating cardiovascular diseases
12/04/2003WO2003099236A1 Allograft bone composition having a gelatin binder
12/04/2003WO2003099037A1 Probiotics and oral tolerance
12/04/2003WO2003083088A3 Stem cell therapy
12/04/2003WO2003077829A3 Process for preparation of a pharmaceutical composition containing acid labile compounds
12/04/2003WO2003068152A3 Purified cytokine inhibitory factor
12/04/2003WO2003066810A3 Recombinant bovine immunodeficiency virus based gene transfer system
12/04/2003WO2003063785A3 Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
12/04/2003WO2003057380A3 Compositions including ammonia oxidizing bacteria and methods of using same
12/04/2003WO2003048338A3 Nucleic acid injected into hepatic vein lumen and delivered to primate liver
12/04/2003WO2003046141A3 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
12/04/2003WO2003040298B1 Cell and tissue growth using substances that reversibly bind oxygen
12/04/2003WO2003029417A3 Nutrient medium for maintaining neural cells in injured nervous system
12/04/2003WO2003024406A3 Nestin-expressing hair follicle stem cells
12/04/2003WO2003008579A3 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby
12/04/2003WO2002096444A3 Plumbago europaea constituents for use against psoriasis and hair loss
12/04/2003WO2002086134A3 Buffer solution for electroporation and a method comprising the use of the same
12/04/2003WO2002082077A3 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
12/04/2003WO2002068635A3 Methods of inhibiting expression of a target gene in mammalian cells
12/04/2003WO2002064827A3 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof
12/04/2003WO2002036806A9 Expression vectors able to elicit improved immune response and methods of using same
12/04/2003WO2001072771A3 Insulin and igf-1 receptor agonists and antagonists
12/04/2003US20030225034 Preventing and treating vaginitis, preterm labor, post-operative pelvis infection, infertility, and sexually transmitted diseases with surfactant lipids, especially surfactant protein A
12/04/2003US20030225021 Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta proteins (TGF-betas) in cells
12/04/2003US20030225001 Preparation of an auricularia auricula polysaccharide and its use in mammals
12/04/2003US20030224980 Diagnostic reagents for human cytomegalovirus and methods of use
12/04/2003US20030224518 Cartilage composites and methods of use
12/04/2003US20030224077 Administration of extracts of nonfruiting nonphotosynthetic filamentous bacteria for increasing the endogenous synthesis of superoxide dismutase
12/04/2003US20030223996 Analyzing the level of B lymphocte stimulator (BLyS) expression in a sample of an individual using antibodies, comparing the level of BLyS assayed in biological sample with a standard level of BLyS expresion in normal sample
12/04/2003US20030223985 Globulin protein to lower cholesterol in humans
12/04/2003US20030223976 Control sequences of the human corin gene
12/04/2003US20030223974 Highly purified hepatic stem cells are trans-differentiated into pancreatic endocrine hormone-producing cells by culturing them in vitro in a medium containing high levels of glucose. These trans differentiated cells express insulin, glucagon and
12/04/2003US20030223972 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
12/04/2003US20030223969 Method of modulating inflammatory response
12/04/2003US20030223968 Protocol of activating and administering human blood cells so that bone marrow histology and/or blood cell counts of patients suffering from aplastic anemia approach normal. The protocol includes culturing the blood cells in the presence of
12/04/2003US20030223961 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
12/04/2003CA2771788A1 Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration
12/04/2003CA2505598A1 A bank of stem cells for transplantation
12/04/2003CA2505592A1 Generation of histocompatible tissues using nuclear transplantation
12/04/2003CA2494134A1 Treatment for diabetes
12/04/2003CA2487858A1 Methods, compositions, and growth and differentiation factors for insulin-producing cells
12/04/2003CA2487811A1 Use of adenoviruses replicating in a yb-1 dependent manner for the treatment of tumors
12/04/2003CA2487452A1 A method for generating antigen-presenting cells
12/04/2003CA2487441A1 Novel uses of parapoxvirus preparations
12/04/2003CA2487143A1 Regulation of novel human asparagine-hydroxylases
12/04/2003CA2487112A1 Neuregulin based methods and compositions for treating cardiovascular diseases
12/04/2003CA2487021A1 Probiotics and oral tolerance
12/04/2003CA2486621A1 Induction and maintenance of tolerance to composite tissue allografts
12/04/2003CA2486620A1 Chimeric allograft tolerance induction, monitoring and maintenance
12/04/2003CA2485816A1 Vaccines
12/03/2003EP1366771A2 Use of the neurotoxic compnent of botulinum toxins as a medicament
12/03/2003EP1366770A2 Use of botulinum toxin for treating muscle-associated pain
12/03/2003EP1366366A2 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
12/03/2003EP1366174A2 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
12/03/2003EP1366169A2 Antigenic proteins of shrimp white spot syndrome virus and uses thereof
12/03/2003EP1366167A2 Biological organism for preparing pharmaceutical compositions for treating mammals
12/03/2003EP1366157A2 Compositions and methods for the therapy and diagnosis of lung cancer
1 ... 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 ... 1259